Published on 13 May 2024 on Simply Wall St. via Yahoo Finance
Insider Spends US$1m Buying More Shares In Corvus Pharmaceuticals
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shareholders (or potential shareholders) will be happy to see that the Co-Founder, Richard Miller, recently bought a whopping US$1m worth of stock, at a price of US$1.73. Aside from being a solid chunk in its own right, the deft move also saw their holding increase by some 39%.
See our latest analysis for Corvus Pharmaceuticals
Corvus Pharmaceuticals Insider Transactions Over The Last Year